Current treatment of toxoplasma retinochoroiditis: an evidence-based review. (Q27693856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Current treatment of toxoplasma retinochoroiditis: an evidence-based review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Petros E. Carvounis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Harrell M

series ordinal

1

1 reference

Carvounis PE

series ordinal

2

1 reference

publication date

13 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

published in

Journal of Ophthalmology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

273506

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

16 February 2020

copyright license

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Clindamycin in the treatment of human ocular toxoplasmosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Corticosteroids for ocular toxoplasmosis

20 March 2017

1 reference

https://api.crossref.org/works/10.1155/2014/273506

Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Outbreak of acquired ocular toxoplasmosis involving 248 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

The visual field in toxoplasmic retinochoroiditis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Treatment of uveitis with pyrimethamine (daraprim)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Azithromycin for ocular toxoplasmosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Laser photocoagulation around the foci of toxoplasma retinochoroiditis: a descriptive statistical analysis of 35 patients with long-term follow-up.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Prophylactic photocoagulation of recurrent toxoplasmic retinochoroiditis. A preliminary report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Treatment of active toxoplasmic retino-choroiditis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Therapy of ocular toxoplasmosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

A comparative study concerning the treatment of active toxoplasmic retinochoroiditis with argon laser and medication (follow-up 2-9 years).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Clindamycin in chronic toxoplasmosis. Effect of periocular injections on recoverability of organisms from healed lesions in the rabbit eye.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

2 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Trimethoprim/Sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Intravitreal clindamycin for toxoplasmic retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Hypersensitivity reaction to intravitreal clindamycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F273506

Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147351

Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis

27 November 2018

1 reference

12 December 2020

Clindamycin therapy for toxoplasmosis

1 reference

12 December 2020

Clindamycin effects on experimental ocular toxoplasmosis in the rabbit

1 reference

12 December 2020

Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine

1 reference

12 December 2020

TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY

1 reference

12 December 2020

Therapy for ocular toxoplasmosis

1 reference

12 December 2020

Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis

1 reference

12 December 2020

SPIRAMYCIN FOR TOXOPLASMOSIS

1 reference

12 December 2020

Treatment of toxoplasmosis uveitis

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/273506

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25197557%20AND%20SRC:MED&resulttype=core&format=json